Please use this identifier to cite or link to this item:
Title: Availability of antiretroviral drugs and patient adherence : a comparison between Malta and Norway
Authors: Namulindwa, Catherine M.
Vella Szijj, Janis
Serracino-Inglott, Anthony
Keywords: Antiretroviral agents -- Treatment -- Malta
Antiretroviral agents -- Treatment -- Norway
Patient compliance -- Malta
Patient compliance -- Norway
Pharmacists -- Interviews
Issue Date: 2018-11
Publisher: University of Malta. Department of Pharmacy
Citation: Namulindwa, C. M., Vella Szijj, J., & Serracino-Inglott, A. (2018, November). Availability of antiretroviral drugs and patient adherence: a comparison between Malta and Norway. Poster session presented at the X Malta Medical School Conference, St Julian's, Malta.
Abstract: A poster presentation regarding the availability of antiretroviral drugs and patient adherence: a comparison between Malta and Norway. Introduction: Newer antiretroviral drugs (ARVs) are recommended as first line agents because they are more tolerable in terms of adverse events, and achieve faster viral suppression. Discontinuation of antiretroviral treatment (ART) due to adverse events was shown to be 4% (16/414) in patients on newer ARVs compared to 14% (58/419) in patients on older ARVs. Malta and Norway have the same prevalence of HIV (0.1%) but different incidence rates. Malta reported an HIV incidence rate of 14.5 per 100,000 population in 2016 compared to 4.2 per 100,000 population in Norway. Aims: ▫ To compare the availability of ARVs in Malta and Norway. ▫ To determine factors associated with availability of ARVs and patient adherence in Malta and Norway.
Appears in Collections:Scholarly Works - FacM&SPha

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.